Bisphenol Compounds on Human Reproduction Health
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2017, Vol 4, Issue 2
Abstract
Bisphenol-A (BPA) is widely used in the plastic industry, and it is one of the well-studied endocrine disrupting chemicals (EDCs). Growing evidence raised the concern of BPA having weak estrogenic activity on human health including female reproductive functions and diseases. Serum BPA level is also associated with pregnancy loss, reproductive tract diseases and infertility. In fact, several countries restricted the use of BPA, and therefore substitutes which share similar chemical and physical properties with BPA were used. However, the effects of these bisphenols (e.g. bisphenol-F (BPF) and bisphenol-S (BPS)) on human reproductive health have not been fully investigated, and this mini-review summarized the recent data of these bisphenols on human reproductive health, and raise the concern on the safety and transgenerational effect of these bisphenols in humans.
Authors and Affiliations
Hongjie Fan
Keywords
Related Articles
- EP ID EP553835
- DOI 10.17140/ GOROJ-4-141
- Views 173
- Downloads 0
Metastatic Cervical Carcinoma with High-Risk Human Papillomavirus (HPV) Positive and P16/ Ki-67 Positive in a 28 Year-Old Female That Did Not Meet the Current Screening Guidelines
A case presentation about an individual treated at Oklahoma State University Medical Center with high-grade metastatic squamous cell carcinoma of the cervix that was high-risk HPV and p16/Ki-67 positive. The clinical pre...
Competing Endoscopic Surgeries in the Era of Assisted Reproductive Technologies: Evidence and Practice
Now-a-days the assisted reproductive technologies (ART) are progressing and advancing rapidly. Many reproductive medicine specialists do believe in ART to be the first choice for infertile women regardless of age related...
The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer
Cervical cancer is the third most prevalent cancer in women globally, with 529,000 diagnosis and 275,000 deaths each year. It is especially prevalent in developing countries where approximately 85% of cases arise due to...
Tumor Conditioning Regimens: An Evolution in Cancer Treatment that Relies on Short-Term Sacrifice for Long-Term Gain
In this commentary, the authors discuss a new concept for tumor treatment, which is based on observations from published studies and clinical practice protocols. This new treatment regimen, which we coin “Tumor Condition...
Heterotopic Pregnancy: A Case Report of Retrospective Diagnosis Following Surgical Treatment
Introduction: Heterotopic pregnancy is a rare occurrence. Very few clinicians may come across heterotopic gestations during their careers. It is a difficult condition to diagnose. It can lead to maternal mortality. Case...